CO4940448A1 - Modificacion a cristal de una sustancia de medicamento - Google Patents

Modificacion a cristal de una sustancia de medicamento

Info

Publication number
CO4940448A1
CO4940448A1 CO98032885A CO98032885A CO4940448A1 CO 4940448 A1 CO4940448 A1 CO 4940448A1 CO 98032885 A CO98032885 A CO 98032885A CO 98032885 A CO98032885 A CO 98032885A CO 4940448 A1 CO4940448 A1 CO 4940448A1
Authority
CO
Colombia
Prior art keywords
medicinal substance
glass modification
modification
difluorbenzyl
triazol
Prior art date
Application number
CO98032885A
Other languages
English (en)
Spanish (es)
Inventor
Robert Portmann
Christoph Hofmeier Urs
Andreas Burkhard
Walter Scherrer
Martin Szelagiewicz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4940448(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO4940448A1 publication Critical patent/CO4940448A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO98032885A 1997-06-10 1998-06-09 Modificacion a cristal de una sustancia de medicamento CO4940448A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10

Publications (1)

Publication Number Publication Date
CO4940448A1 true CO4940448A1 (es) 2000-07-24

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
CO98032879A CO4940452A1 (es) 1997-06-10 1998-06-09 Modificacion a cristal de una sustancia activa de medicamen- to
CO98032885A CO4940448A1 (es) 1997-06-10 1998-06-09 Modificacion a cristal de una sustancia de medicamento

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CO98032879A CO4940452A1 (es) 1997-06-10 1998-06-09 Modificacion a cristal de una sustancia activa de medicamen- to

Country Status (36)

Country Link
US (6) US6740669B1 (enExample)
EP (2) EP0994863B1 (enExample)
JP (2) JP3672575B2 (enExample)
KR (2) KR100409168B1 (enExample)
CN (3) CN1159300C (enExample)
AR (4) AR012946A1 (enExample)
AT (2) ATE237599T1 (enExample)
AU (2) AU725528B2 (enExample)
BR (2) BR9804947A (enExample)
CA (3) CA2256015C (enExample)
CO (2) CO4940452A1 (enExample)
CY (1) CY2007014I2 (enExample)
CZ (2) CZ292481B6 (enExample)
DE (3) DE69811500T2 (enExample)
DK (2) DK0994863T3 (enExample)
ES (2) ES2197485T3 (enExample)
FR (1) FR07C0037I2 (enExample)
HU (2) HU225153B1 (enExample)
ID (2) ID21014A (enExample)
IL (2) IL125733A (enExample)
LU (1) LU91345I2 (enExample)
MY (2) MY125854A (enExample)
NL (1) NL300284I2 (enExample)
NO (2) NO329315B1 (enExample)
NZ (2) NZ331371A (enExample)
PE (2) PE80999A1 (enExample)
PL (2) PL192114B1 (enExample)
PT (1) PT994864E (enExample)
RU (2) RU2194041C2 (enExample)
SI (2) SI0994864T1 (enExample)
SK (2) SK283685B6 (enExample)
TR (2) TR199801630T1 (enExample)
TW (2) TW403740B (enExample)
UY (1) UY25844A1 (enExample)
WO (2) WO1998056772A1 (enExample)
ZA (2) ZA984967B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
AR040233A1 (es) * 2002-05-31 2005-03-23 Schering Corp Polimorfos inhibidores de xantina fosfodiesterasa v
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
NZ591725A (en) 2008-10-13 2012-09-28 Cipla Ltd PROCESS FOR THE PREPARATION OF RUFINAMIDE which is also known as 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
KR101597338B1 (ko) * 2009-09-04 2016-02-24 탁티칼 떼라페우틱스 인크. 5-아미노 또는 치환된 아미노 1,2,3-트리아졸 화합물 및 이의 오로트산염 제형들의 신규한 조성물들 및 이의 제조방법
JP2013525413A (ja) * 2010-04-30 2013-06-20 ラボラトリオス レスヴィ，エス．エル． ルフィナマイド中間体の改良された製造方法
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
WO2014013511A2 (en) * 2012-07-20 2014-01-23 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
FI834666A7 (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
PH22568A (en) * 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
WO1991001724A1 (en) 1989-07-27 1991-02-21 G.D. Searle & Co. Renal-selective prodrugs for the treatment of hypertension
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
CA2095444C (en) 1990-11-06 2001-06-19 Shuichi Sakamoto Fused pyrazine derivatives
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
ATE194607T1 (de) 1995-02-22 2000-07-15 Hoechst Japan Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung
SI0918758T1 (en) * 1996-07-11 2002-10-31 Novartis Ag Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Also Published As

Publication number Publication date
HUP0002113A3 (en) 2002-09-30
HK1028241A1 (en) 2001-02-09
CN1259127A (zh) 2000-07-05
JP2000516259A (ja) 2000-12-05
IL125732A0 (en) 1999-04-11
CY2007014I1 (el) 2009-11-04
AR061004A2 (es) 2008-07-30
SK109398A3 (en) 1998-12-02
DE122007000051I2 (de) 2009-02-19
US8076362B2 (en) 2011-12-13
DE69813560T2 (de) 2004-02-05
CZ253498A3 (cs) 1999-04-14
SI0994863T1 (en) 2003-08-31
JP3672574B2 (ja) 2005-07-20
AR012945A1 (es) 2000-11-22
RU2198167C2 (ru) 2003-02-10
US20100310655A1 (en) 2010-12-09
DE69813560D1 (de) 2003-05-22
JP2000516258A (ja) 2000-12-05
ES2197485T3 (es) 2004-01-01
US6740669B1 (en) 2004-05-25
EP0994864A1 (en) 2000-04-26
KR19990087836A (ko) 1999-12-27
US20040167186A1 (en) 2004-08-26
HK1028242A1 (en) 2001-02-09
NO329314B1 (no) 2010-09-27
AU8437298A (en) 1998-12-30
US20030125568A1 (en) 2003-07-03
CN1572789A (zh) 2005-02-02
DE69811500D1 (de) 2003-03-27
EP0994863A1 (en) 2000-04-26
US20010037029A1 (en) 2001-11-01
SI0994864T1 (en) 2003-10-31
DK0994864T3 (da) 2003-07-21
FR07C0037I1 (enExample) 2007-08-17
HUP0000798A3 (en) 2000-10-30
CA2614926A1 (en) 1998-12-17
ATE232852T1 (de) 2003-03-15
IL125733A (en) 2002-12-01
ID21014A (id) 1999-04-08
NO983667L (no) 1998-12-17
KR19990087835A (ko) 1999-12-27
MY125854A (en) 2006-08-30
PL330764A1 (en) 1999-05-24
NO983666D0 (no) 1998-08-11
CN1159300C (zh) 2004-07-28
AR012946A1 (es) 2000-11-22
SK109498A3 (en) 1998-12-02
CZ292481B6 (cs) 2003-09-17
NO329315B1 (no) 2010-09-27
DE122007000051I1 (de) 2007-11-08
LU91345I9 (enExample) 2018-12-31
CA2256015A1 (en) 1998-12-17
KR100409168B1 (ko) 2004-01-31
ES2192779T3 (es) 2003-10-16
TW526195B (en) 2003-04-01
CY2007014I2 (el) 2009-11-04
NO983666L (no) 1998-12-17
PE80999A1 (es) 1999-09-06
ZA984966B (en) 1999-01-11
LU91345I2 (fr) 2007-09-04
WO1998056773A1 (en) 1998-12-17
CN1298708C (zh) 2007-02-07
CA2256013A1 (en) 1998-12-17
PL192114B1 (pl) 2006-08-31
DE69811500T2 (de) 2004-04-01
HUP0000798A2 (hu) 2000-10-30
ZA984967B (en) 1999-01-11
PE79799A1 (es) 1999-09-03
EP0994863B1 (en) 2003-02-19
EP0994864B1 (en) 2003-04-16
HUP0002113A2 (hu) 2001-02-28
AR061005A2 (es) 2008-07-30
US7750028B2 (en) 2010-07-06
CN1217716A (zh) 1999-05-26
CA2256013C (en) 2007-10-16
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
TW403740B (en) 2000-09-01
RU2194041C2 (ru) 2002-12-10
ID27660A (id) 2001-04-19
NZ331371A (en) 2000-08-25
TR199801631T1 (xx) 1999-06-21
BR9804946A (pt) 1999-08-24
IL125733A0 (en) 1999-04-11
HK1028031A1 (en) 2001-02-02
NZ331370A (en) 2000-08-25
PL191943B1 (pl) 2006-07-31
SK283734B6 (sk) 2003-12-02
BR9804947A (pt) 1999-08-24
IL125732A (en) 2002-12-01
DK0994863T3 (da) 2003-05-26
CN1132820C (zh) 2003-12-31
WO1998056772A1 (en) 1998-12-17
CA2614926C (en) 2010-02-09
CO4940452A1 (es) 2000-07-24
PL330798A1 (en) 1999-06-07
UY25844A1 (es) 2001-08-27
FR07C0037I2 (enExample) 2008-05-16
US6455556B2 (en) 2002-09-24
US20060116520A1 (en) 2006-06-01
AU8437198A (en) 1998-12-30
MY120156A (en) 2005-09-30
HU225153B1 (en) 2006-07-28
CZ253398A3 (cs) 1999-04-14
SK283685B6 (sk) 2003-12-02
AU725528B2 (en) 2000-10-12
CA2256015C (en) 2008-06-03
HU226107B1 (en) 2008-04-28
JP3672575B2 (ja) 2005-07-20
CZ292260B6 (cs) 2003-08-13
ATE237599T1 (de) 2003-05-15
TR199801630T1 (xx) 1999-06-21
AU725517B2 (en) 2000-10-12
NL300284I2 (nl) 2007-11-01
KR100425656B1 (ko) 2004-05-17
PT994864E (pt) 2003-07-31

Similar Documents

Publication Publication Date Title
SE8804629D0 (sv) New therapeutically active compounds
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
SE9504661D0 (sv) New compounds
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
ES2185711T3 (es) 1,4-benzotiazepina-1,1-dioxidoshipolipimemicos.
SE8700499D0 (sv) Novel pharmacologically active compounds
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
SE9904505D0 (sv) Novel compounds
ES2084702T3 (es) Imidazoles sustituidos utiles como inhibidores de la angiotensina ii.
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
FI954612L (fi) Uusia imidatsolidiinejä, jotka on substituoitu heterosyklillä, niiden valmistusmenetelmä ja -välituotetteita, niiden käyttö lääkkeinä ja niitä sisältävät farmaseuttiset koostumukset
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
ATE360428T1 (de) Analgetisches arzneimittel
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
BR9812443A (pt) 1-2-3-4-5-6-hexahidro-2,6-metano-3-benzazocin-10-óis substituìdos, processos para sua preparação e seu emprego como medicamentos
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
PA7801701A1 (es) Compuestos ariltios
UY27372A1 (es) Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados